AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 31,298 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 9, 2026 · Filed Nov 10, 2026

On Nov 9, 2026, Equels Thomas K (Director, CEO & President) bought 31,298 AIM ImmunoTech Inc. shares at US$0.16 for US$5,070, leaving 254,095 shares. Filed Nov 10, 2026 (Form 4).

Bought
31,298 shares
Price
US$0.16
Value
US$5,070
Holding after
254,095 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 9, 2026Common StockBuy31,298US$0.16254,095Direct

Source

Download original · View original at SEC

Related